» Articles » PMID: 38478321

Understanding the Dynamics of Human Defensin Antimicrobial Peptides: Pathogen Resistance and Commensal Induction

Overview
Date 2024 Mar 13
PMID 38478321
Authors
Affiliations
Soon will be listed here.
Abstract

Antimicrobial peptides (AMPs), also known as host defense peptides, are petite molecules with inherent microbicidal properties that are synthesized by the host's innate immune response. These peptides serve as an initial barrier against pathogenic microorganisms, effectively eliminating them. Human defensin (HD) AMPs represent a prominent group of peptides involved in the innate immune response of humans. These peptides are primarily produced by neutrophils and epithelial cells, serving as a crucial defense mechanism against invading pathogens. The extensive research conducted has focused on the broad spectrum of antimicrobial activities and multifaceted immunomodulatory functions exhibited by human defensin AMPs. During the process of co-evolution between hosts and bacterial pathogens, bacteria have developed the ability to recognize and develop an adaptive response to AMPs to counterattack their bactericidal activity by different antibiotic-resistant mechanisms. However, numerous non-pathogenic commensal bacteria elicit the upregulation of defensins as a means to surmount the resistance mechanisms implemented by pathogens. The precise mechanism underlying the induction of HD by commensal organisms remains to be fully understood. This review summarizes the most recent research on the expression of human defensin by pathogens and discusses the various defense mechanisms used by pathogens to counter host AMP production. We also mention recent developments in the commensal induction of defensin AMPs. A better knowledge of the pathogens' defensin AMP resistance mechanisms and commensals' induction of AMP expression may shed light on the creation of fresh antibacterial tactics to get rid of bacterial infection.

Citing Articles

Amniotic membrane, a novel bioscaffold in cardiac diseases: from mechanism to applications.

Rayat Pisheh H, Darvishi A, Masoomkhah S Front Bioeng Biotechnol. 2025; 12:1521462.

PMID: 39758951 PMC: 11696288. DOI: 10.3389/fbioe.2024.1521462.


Cyclization increases bactericidal activity of arginine-rich cationic cell-penetrating peptide for .

John C, Otala S, Jarvis G Microbiol Spectr. 2024; 12(9):e0099724.

PMID: 39105587 PMC: 11370255. DOI: 10.1128/spectrum.00997-24.

References
1.
Aberg K, Radek K, Choi E, Kim D, Demerjian M, Hupe M . Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J Clin Invest. 2007; 117(11):3339-49. PMC: 2045593. DOI: 10.1172/JCI31726. View

2.
Bachrach G, Altman H, Kolenbrander P, Chalmers N, Gabai-Gutner M, Mor A . Resistance of Porphyromonas gingivalis ATCC 33277 to direct killing by antimicrobial peptides is protease independent. Antimicrob Agents Chemother. 2007; 52(2):638-42. PMC: 2224744. DOI: 10.1128/AAC.01271-07. View

3.
Belas R, Manos J, Suvanasuthi R . Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides. Infect Immun. 2004; 72(9):5159-67. PMC: 517467. DOI: 10.1128/IAI.72.9.5159-5167.2004. View

4.
Belkacem N, Bourdet-Sicard R, Taha M . Lactobacillus paracasei feeding improves the control of secondary experimental meningococcal infection in flu-infected mice. BMC Infect Dis. 2018; 18(1):167. PMC: 5894232. DOI: 10.1186/s12879-018-3086-9. View

5.
Bevins C . Innate immune functions of α-defensins in the small intestine. Dig Dis. 2013; 31(3-4):299-304. DOI: 10.1159/000354681. View